Bromhexine is almost completely metabolized and is a Cyp3A4 substrate. It is not listed as an inducer or MBI of CYPs and in therapeutic use no drug-drug interactions involving CYP enzymes has been observed.
Therapeutic characteristics
Bromhexine is indicated for respiratory disorders with viscous mucus.
Metabolism and pharmacokinetics
Bromhexine is almost completely metabolized. The half-life elimination is 1 hour. Ambroxol is a metabolite of bromhexine and in vitro studies have shown that it is metabolized by CYP3A4 (Ischiguro 2000). In vitro studies have also shown that ambroxol is a weak inhibitor (Ischiguro 2000), which indicates that the potential for drug-drug interactions is low (Ischiguro 2000 and Malerba 2008). The Summary of Product Characteristics also states that interactions with CYP2C9 and CYP3A4 are unlikely and in pharmacotherapeutic use no clinically significant DDIs has been observed (DRUID, Interaktionsdatabasen). This indicates that bromhexine or its metabolites do not act as inducers or inhibitors of CYP enzymes in vivo.
IPNet drug reports
Uneventful use reported in 9 patients with acute porphyria.
Similar drugs
Explore alternative drugs in similar therapeutic classes
R05C /
R05CB or
go back.
References
#
Citation details
PMID
*
Scientific articles
1.
Identification of CYP3A4 as the predominant isoform responsible for the metabolism of ambroxol in human liver microsomes.
Ishiguro N, Senda C, et al. Xenobiotica. 2000 Jan;30(1):71-80.
2.
Ambroxol in the 21st century: pharmacological and clinical update.
Malerba M, Ragnoli B. Expert Opin Drug Metab Toxicol. 2008 Aug;4(8):1119-29.
Norwegian medicines agency. Summary of Product Characteristics (SPC). Bromhexin.
Tradenames
This list comprises raw data collected from different countries.
In some cases, a more comprehensive list of available drug packages is included.
Consequently, very similar terms may therefore appear multiple times.
Bold names are the searchable terms, while the gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors.
We strive to improve it continuously.